Alameda, CA, United States of America

Edward Kupa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbott Diabetes Care Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward Kupa: Innovator in Analyte Sensor Technology

Introduction

Edward Kupa is a notable inventor based in Alameda, CA (US). He has made significant contributions to the field of analyte sensor technology. His innovative work has led to the development of a patented method that enhances the functionality and assembly of sensor devices.

Latest Patents

Edward Kupa holds a patent for "Systems, devices, and methods for an analyte sensor." This patent describes a method that includes assembling a sensor subassembly comprising a sensor, a sensor mount, a collar, a sharp, and a sensor cap. The method involves loading a sensor into a sensor mount, dispensing adhesive into a mount channel, clamping a collar to the sensor mount, and curing the adhesive to secure the collar. Additionally, the method includes inserting a sharp into the sensor mount and attaching a sensor cap to create a sealed sensor subassembly. The patent also discloses methods for assembling an on-body sensor puck assembly and an applicator assembly.

Career Highlights

Edward Kupa is currently employed at Abbott Diabetes Care Inc., where he continues to innovate in the field of diabetes management technology. His work focuses on improving sensor technologies that are crucial for monitoring glucose levels in patients.

Collaborations

Throughout his career, Edward has collaborated with talented individuals such as Jean-Pierre Cole and Peter Voit. These collaborations have contributed to the advancement of sensor technology and the development of new methods in the field.

Conclusion

Edward Kupa is a dedicated inventor whose work in analyte sensor technology has made a significant impact. His innovative methods and collaborations continue to drive advancements in diabetes care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…